Mylan Inc. (MYL) is in the Pharma Industry

Mylan is engaged in the development, licensing, manufacture, marketing and distribution of generic, brand and branded generic pharmaceutical products for resale by others and active pharmaceutical ingredients. As of Dec 31 2007, Co. operated through two reportable segments: the Mylan Segment, which the principal markets for its products are proprietary and ethical pharmaceutical wholesalers and distributors, drug store chains, drug manufacturers, institutions, and public and governmental agencies within the U.S.; and the Matrix Segment, which the principal markets are regulated markets such as the U.S. and the European Union.